Cleared Special

K171822 - NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352)

K171822 is an FDA 510(k) clearance for NuvoMed Wireless Blood Glucose Monitori..., manufactured by Biotest Medical Corporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 93-day FDA review.

K171822 · Biotest Medical Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
93d
Days
Class 2
Risk

K171822 is an FDA 510(k) clearance for the NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352). Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Biotest Medical Corporation (Taichung, TW). The FDA issued a Cleared decision on September 20, 2017 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biotest Medical Corporation devices

FDA 510(k) Submission Details - K171822

510(k) Number K171822 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 2017
Decision Date September 20, 2017
Days to Decision 93 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 88d · This submission: 93d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 420
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K171822.
Tyson Bio HT100 Blood Glucose Monitoring System, Tyson Bio HT100-B Blood Glucose Monitoring System
K170079 · Tyson Bioresearch, Inc. · Oct 2017
Gold AQ Blood Glucose Monitoring System
K170264 · Changsha Sinocare, Inc. · Oct 2017
FreeStyle Precision Neo Blood Glucose Test Strips
K171941 · Abbott Diabetes Care, Inc. · Sep 2017
iHealth Align Gluco-Monitoring System (BG1)
K170231 · Andon Health Co, Ltd. · Sep 2017
WowGoHealth Blood Glucose Monitoring System
K171785 · Biotest Medical Corporation · Sep 2017
GLUCOCARD W Blood Glucose Monitoring System
K170064 · Arkray Factory, Inc. · Aug 2017